Abstract

Introduction: Invasive fungal infections are an important nosocomial health problem, candidal infections being the most common. Candidal bloodstream infections (BSIs) account for one-fourth of the nosocomial BSIs. Candida albicans once the most common has now been replaced by nonalbicans Candida, accounting for majority of cases of candidal infections. The knowledge and understanding of specific risk factors, epidemiology, prophylactic measures, and outcomes with relation to speciation are changing rapidly. Emergence of antifungal resistance is a cause of concern. With this background, a prospective study was undertaken. Aims and Objectives: To isolate Candida spp. from blood cultures of patients with clinically diagnosed or suspected septicemia; to identify and speciate Candida isolates and carry out the antifungal susceptibility test; to determine incidence of candidemia; to find out the crude mortality rate in candidemia patients. Materials and Methods: Blood cultures received in the Department of Microbiology from various critical care units over a 1-year period were included in this study. Samples were cultured on Sabouraud dextrose agar and routine bacteriological cultures. Speciation of suspected Candida growth was done by conventional and automated system. Results: A total of 225 out of 839 blood cultures were culture positive. A total of 196 were bacterial pathogens. Candida spp. were isolated in 29 samples. These included 10 cases of Candida tropicalis, 8 Candida parapsilosis, and three cases each of C. albicans and Candida krusei. Fluconazole resistance was seen (minimum inhibitory concentration ≥64 μg/ml) in 4 isolates, 2 of C. krusei and 2 of Candida haemulonii. Incidence of candidemia was 3.46%. Crude mortality rate in the present study was 24%.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call